Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
23 Leser
Artikel bewerten:
(0)

MedQuist Introduces CodeRunner With Computer-Assisted Coding / Automated Coding Solution Positions Healthcare Providers for ICD-10

MT. LAUREL, N.J., Sept. 28 /PRNewswire/ -- MedQuist Inc. , a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow, announces the introduction of CodeRunner(TM) with Computer-Assisted Coding (CAC) technology for improved coding productivity, efficiency, cost savings and reimbursement.

According to Christopher Spring, MedQuist vice president of Product Management, "CodeRunner CAC offers a smooth transition to upcoming ICD-10. Many healthcare facilities are already finding it difficult to keep up with coding volumes and regional requirements using their existing workforce and technology. With solid preparation and proper technology now, providers will be able to meet the complexity of the expanded code sets that ICD-10 will bring in 2013."

MedQuist's transcription solutions feed clinical documents directly into CodeRunner CAC - speeding the coding process and helping providers to obtain reimbursement faster. In addition, this mature coding automation technology can:

-- Lower a facility's DNFBs (Discharged Not Final Billed), by sending coded records directly to Billing with minimal or no auditing; -- Reduce coding turnaround times and denials; -- Enable coders to be more accurate and to focus their knowledge more on results, exceptions and complex charts; and -- Help providers do more with less, by eliminating the need to handle coding backlogs and overflow by paying overtime.

Observes Spring, "Even before converting to ICD-10, automating the process will be important for meeting coding volumes and the need to be more consistent and productive. By letting the technology enhance the coding workflow, facilities can stay ahead of the workforce challenges that they will face with these upcoming changes in the industry."

MedQuist offers an industry-leading healthcare information management platform (DocQment Enterprise Platform® or DEP), which serves as the foundation for its transcription service offerings and includes workflow management, core measures reporting, structured documentation, data analytics, and key customer reporting. Other MedQuist solutions include SpeechQ® real-time interactive speech recognition for radiology and general medicine, DocQvoice® for capturing dictation, and computer-assisted coding and abstracting. This blend of solutions drives document quality and accuracy and advances the adoption of Electronic Health Records - resulting in improved patient care and higher levels of efficiency.

About MedQuist

MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions - including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors - help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit http://www.medquist.com/.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

MedQuist Inc.

CONTACT: Katie Weaver, Marketing Communications, +1-267-940-5765,
kweaver@medquist.com

Web Site: http://www.medquist.com/

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2010 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.